Group | Patients | p = | Comment | ||
AF | Total | AF% | |||
CHF ≥ 75 y.o. | 88 | 130 | 67.69% | 0.0073 | (95% CL 59.23, 75.14%, O.R. 2.88) |
CHF < 75 y.o. | 16 | 38 | 42.11% | ||
CHF + Hi BP | 93 | 152 | 61.18% | 0.7875 | |
CHF Nl BP | 9 | 16 | 56.25% | ||
CHF + CAD | 41 | 72 | 56.94% | 0.2654 | |
CHF no CAD | 63 | 96 | 65.63% | ||
CHF + DM | 27 | 51 | 52.94% | 0.1233 | |
CHF no DM | 77 | 117 | 65.81% | ||
CHF + LAE | 90 | 128 | 70.31% | <0.0001 | (CL 61.88%, 77.56%, O.R. 6.81) |
CHF no LAE | 8 | 31 | 25.81% | ||
CHF + LVE | 19 | 29 | 65.52% | 0.8335 | |
CHF no LVE | 81 | 130 | 62.31% | ||
≥75 + CHF | 88 | 130 | 67.69% | <0.0001 | (CL 59.23, 75.14%, O.R. 3.45) |
≥75 no CHF | 150 | 397 | 37.78% | ||
Hi BP + CHF | 95 | 152 | 62.50% | <0.0001 | (CL 54.58, 69.81%, O.R. 4.57) |
Hi BP no CHF | 169 | 632 | 26.74% | ||
CAD + CHF | 41 | 72 | 56.94% | 0.0055 | (CL 45.44, 67.75%, O.R. 2.22) |
CAD no CHF | 62 | 168 | 36.90% | ||
DM + CHF | 27 | 51 | 52.94% | 0.0307 | (CL 39.52, 65.95%, O.R. 2.12) |
DM no CHF | 53 | 153 | 34.64% |